MXPA04002407A - Use of 4-pyridylmethylphthalazines for cancer treatment. - Google Patents

Use of 4-pyridylmethylphthalazines for cancer treatment.

Info

Publication number
MXPA04002407A
MXPA04002407A MXPA04002407A MXPA04002407A MXPA04002407A MX PA04002407 A MXPA04002407 A MX PA04002407A MX PA04002407 A MXPA04002407 A MX PA04002407A MX PA04002407 A MXPA04002407 A MX PA04002407A MX PA04002407 A MXPA04002407 A MX PA04002407A
Authority
MX
Mexico
Prior art keywords
pyridylmethylphthalazines
cancer treatment
phthalazine
pyridylmethyl
treated
Prior art date
Application number
MXPA04002407A
Other languages
Spanish (es)
Inventor
Marjorie Wood Jeanette
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP2002/010194 external-priority patent/WO2003022282A1/en
Publication of MXPA04002407A publication Critical patent/MXPA04002407A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patients suffering from renal carcinoma are treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agents. Patients having different tumor types, e.g. renal cancer, are treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agent while undergoing chemotherapy.
MXPA04002407A 2001-09-12 2002-09-11 Use of 4-pyridylmethylphthalazines for cancer treatment. MXPA04002407A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31869401P 2001-09-12 2001-09-12
US33102501P 2001-09-12 2001-09-12
US33204401P 2001-09-14 2001-09-14
US38816302P 2002-06-12 2002-06-12
PCT/EP2002/010194 WO2003022282A1 (en) 2001-09-12 2002-09-11 Use of 4-pyridylmethylphthalazines for cancer treatment

Publications (1)

Publication Number Publication Date
MXPA04002407A true MXPA04002407A (en) 2004-05-31

Family

ID=34109073

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002407A MXPA04002407A (en) 2001-09-12 2002-09-11 Use of 4-pyridylmethylphthalazines for cancer treatment.

Country Status (1)

Country Link
MX (1) MXPA04002407A (en)

Similar Documents

Publication Publication Date Title
HUP0200093A2 (en) Trpm-2 antisense therapy
HK1061199A1 (en) Pharmaceutical compositions comprising arsenic trioxide for the treatment of multiple myeloma
WO2004050026A3 (en) Compositions and methods for treating prostate cancer
ATE425749T1 (en) TREATMENT OF HER-2/NEW OVEREXPRESSION-ASSOCIATED CANCER
WO2002092854A3 (en) Genes expressed in breast cancer as prognostic and therapeutic targets
UA70925C2 (en) Method for treatment and prevention of estrogen-dependent diseases and disorders
MXPA04003674A (en) Improved use of antitumoral compound in cancer therapy.
HUP0500424A2 (en) Combination therapy for the treatment of cancer
HK1068261A1 (en) Combinations comprisinga selective cyclooxygenase-2 inhibitor
MXPA03008582A (en) Agents and methods for treatment of cancer.
AU2003219555A8 (en) Depsipeptide for therapy of kidney cancer
RS16804A (en) Use of 4-pyridylmethylphthalazines for cancer treatment
HK1056692A1 (en) Proteins
GB0129457D0 (en) Method of treatment
MXPA04002407A (en) Use of 4-pyridylmethylphthalazines for cancer treatment.
BG108932A (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
WO2000037065A3 (en) Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
ECSP044991A (en) USE OF 4-PIRIDILMETIL-FTALAZINAS FOR THE TREATMENT OF CANCER
MX2007000477A (en) Treatment of tumours.
WO2005048956A3 (en) Estradiol-related compounds and methods of use as anti-tumor agents
MX9701832A (en) New pro-medicine for tumor therapy and inflammatory diseases.
EA200600987A1 (en) APPLICATION OF SYRAMEZIN IN THE TREATMENT OF MALIGNANT TUMORS

Legal Events

Date Code Title Description
FG Grant or registration